Related references
Note: Only part of the references are listed.Transcriptional and epigenetic regulation of macrophages in atherosclerosis
Tatyana Kuznetsova et al.
NATURE REVIEWS CARDIOLOGY (2020)
Decreased M1 macrophage polarization in dabigatran-treated Ldlr-deficient mice: Implications for atherosclerosis and adipose tissue inflammation
Kathrin Feldmann et al.
ATHEROSCLEROSIS (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections
Marcel Muenstermann et al.
VIRULENCE (2019)
Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council
Peggy Robinet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Animal models of atherosclerosis
Besa Emini Veseli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse
Katharina M. Quell et al.
JOURNAL OF IMMUNOLOGY (2017)
Novel insights into the expression pattern of anaphylatoxin receptors in mice and men
Yves Laumonnier et al.
MOLECULAR IMMUNOLOGY (2017)
C5aR1 promotes acute pyelonephritis induced by uropathogenic E. coli
Ke Li et al.
JCI INSIGHT (2017)
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies A Scientific Statement From the American Heart Association
Alan Daugherty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization
Liang Bai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis
Naheed Choudhry et al.
KIDNEY INTERNATIONAL (2016)
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth
Liam G. Coulthard et al.
JOURNAL OF IMMUNOLOGY (2015)
Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice
Jaco Selle et al.
THROMBOSIS AND HAEMOSTASIS (2015)
The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization
Mike C. L. Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Immunization With a Combination of 2 Peptides Derived From the C5a Receptor Significantly Reduces Early Atherosclerotic Lesion in Ldlrtm1Her Apobtm2SgyJ Mice
Xinjie Lu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice
Helga D. Manthey et al.
FASEB JOURNAL (2011)
Deficiency of C5aR Prolongs Renal Allograft Survival
Qijun Li et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
C3a receptor deficiency accelerates the onset of renal injury in the MRL/Ipr mouse
Scott E. Wenderfer et al.
MOLECULAR IMMUNOLOGY (2009)
Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing
M. Wysoczynski et al.
LEUKEMIA (2009)
The multiple facets of mTOR in immunity
Thomas Weichhart et al.
TRENDS IN IMMUNOLOGY (2009)
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart et al.
IMMUNITY (2008)
Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: Opposing roles of C3a and C5a
Travis J. Hollmann et al.
MOLECULAR IMMUNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Functional roles for C5a receptors in sepsis
Daniel Rittirsch et al.
NATURE MEDICINE (2008)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
C5a receptor deficiency attenuates T cell function and renal disease in MRL1pr mice
SE Wenderfer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice
L Persson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Influence of C3 deficiency on atherosclerosis
C Buono et al.
CIRCULATION (2002)
Cutting edge: Targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock
J Kildsgaard et al.
JOURNAL OF IMMUNOLOGY (2000)
A role for the C3a anaphylatoxin receptor in the effector phase of asthma
AA Humbles et al.
NATURE (2000)
Share Paper
